Bevacizumab/everolimus/sorafenib/sunitinibGallbladder complications: 6 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2015年 / 1545卷 / 1期

关键词：

D O I：

10.1007/s40278-015-9149-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：58 / 58

相关论文

共 50 条

[21] Bevacizumab/irinotecan/polyethylene glycolVarious toxicities: 6 case reports
[J]. Reactions Weekly, 2018, 1721 (1) : 62 - 62
[22] Bevacizumab/sorafenib/temsirolimusMucositis and fatigue: case report
[J]. Reactions Weekly, 2016, 1588 (1) : 52 - 52
[23] Bevacizumab/sorafenib/temsirolimusVarious toxicities: case report
[J]. Reactions Weekly, 2014, 1517 (1) : 43 - 43
[24] Bevacizumab/sorafenib/sunitinibVarious toxicities: case report
[J]. Reactions Weekly, 2011, 1366 (1) : 7 - 7
[25] Dabigatran-etexilateHaemorrhagic complications: 6 case reports
[J]. Reactions Weekly, 2018, 1695 (1) : 137 - 137
[26] Everolimus/sorafenib interactionFatal gastrointestinal bleeding: case report
[J]. Reactions Weekly, 2013, 1448 (1) : 17 - 17
[27] Bevacizumab/cetuximabRash, hypertension, gastrointestinal bleed, and headache: 6 case reports
[J]. Reactions Weekly, 2016, 1585 (1) : 52 - 52
[28] Everolimus/ridaforolimusStomatitis: 17 case reports
[J]. Reactions Weekly, 2011, 1382 (1) : 20 - 20
[29] Everolimus/sirolimusLymphoedema: 13 case reports
[J]. Reactions Weekly, 2021, 1881 (1) : 122 - 122
[30] Sorafenib/sunitinibPancytopenia?: 2 case reports
[J]. Reactions Weekly, 2011, 1374 (1) : 32 - 32

← 1 2 3 4 5 →